Author:
Zieroth Shelley,Rizi Shekoofeh Saboktakin
Subject
Cardiology and Cardiovascular Medicine
Reference5 articles.
1. The four pillars of HFrEF therapy: is it time to treat heart failure regardless of ejection fraction?;Docherty;Eur Hear J Suppl,2022
2. SGLT-2 inhibitors in patients with heart failure: a comprehensive meta-analysis of five randomised controlled trials;Vaduganathan;Lancet,2022
3. Recency of heart failure hospitalization, outcomes, and the effect of empagliflozin: an EMPEROR-Pooled analysis;Ferreira;J Am Coll Cardiol HF,2023
4. Shahid I, Fonarow GC, Greene SJ. Time to quadruple guideline-directed medical therapy as a key performance measure for heart failure. J Card Fail. 2023;29(5):730-733. https://doi.org/10.1016/j.cardfail.2023.02.012
5. Moghaddam N, Hawkins NM, McKelvie R, et al. Patient eligibility for established and novel guideline-directed medical therapies after acute heart failure hospitalization. J Am Coll Cardiol HF. 2023;11(5):596-606. https://doi.org/10.1016/j.jchf.2022.10.013